Penn Rheumatology

Penn Rheumatology Faculty Members

faculty photo

Chris T Derk, MD, MS

Associate Professor of Clinical Medicine
Fellowship Program Director, Division of Rheumatology
Department: Medicine

Contact information
Division of Rheumatology
8th Floor Penn Tower
One Convention Blvd
Philadelphia, PA 19104
Office: 215-615-4306
Fax: 215-662-4500
Education:
AA
Harrisburg Area Community College, 1988.
BS (Pre-Medicine)
Pennsylvania State University, 1990.
MD
Thomas Jefferson University, 1994.
MSc (Pharmacology)
Thomas Jefferson University, 2006.
Post-Graduate Training
Intern, Medicine, Abington Memorial Hospital, Abington, PA, 1994-1995.
Resident, Medicine, Abington Memorial Hospital, Abington, PA, 1995-1997.
NIH Research Postdoctoral Fellow in Molecular Rheumatology and Orthopedic Research, Thomas Jefferson University, Philadelphia, PA, 2001-2003.
Fellow, Rheumatology, , Thomas Jefferson University, Philadelphia, PA, 2001-2003.
K30 Clinical Research Pharmacology MS degree, Thomas Jefferson College of Graduate Studies, Philadelphia, PA, 2002-2006.
Certifications
Rheumatology, 2003.
Rheumatology, 2013.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Saketkoo lA et al. : Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease-related Interstitial Lung Diseases. J Rheumatol 41(4): 792-8, April 2014.

Mecoli C, Purohit S, Sandorfi N, Derk CT: Mortality, Recurrence, and hospital course of patients with systemic sclerosis-related acute intestinal pseudo-obstruction. J Rheumatol 2014.

Hsu VM et al. : Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. Semin Arthritis Rheum S0049-0172(14)00042-0, 2014.

Abraham M, Derk CT: Anti-Ribosomal- P antibodies in lupus nephritis, neuropsychiatric lupus, lupus hepatitis and Chaga's disease: promising yet limited in clinical utility. Rheumatol Int 2014.

Sehra ST, Derk CT: Disease modification in systemic sclerosis; the search for the Holy Grail. International Journal of Clinical Rheumatology 8(6): 611-613, December 2013.

Snigdha, J; Shahane, A; Derk CT. : Treatment decisions in interstitial lung disease. Novel insights into systemic sclerosis management. Future Medicine, Page: 149-59, October 2013.

Chung L, Domsic RT, Lingala B, Alkassab F, Bolster M, Csuka ME, Derk C, et al: Survival and predictors of mortality in systemic sclerosis associated pulmonary arterial hypertension; outcomes from the PHAROS registry. Arthritis Care Research 2013.

Mecoli C, Purohit S, Sandorfi N, Derk CT: Mortality, Recurrence and Hospital course of patients with systemic sclerosis related acute intestinal pseudo-obstruction. Annual Scientific meeting of the American College of Rheumatology 2013.

Saketkoo LA et al. : Connective tissue disease related interstitial lung disease and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials. Thorax 2013.

Gnrenassia E, Avouac J, Khanna D, Derk CT, et al: Prevalence, correlates and outcomes of gastric antral vascular ectasiain systemic sclerosis: A EUSTAR case-control study. Journal of Rheumatology 2013.

back to top
Last updated: 09/05/2014
The Trustees of the University of Pennsylvania